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Simple Summary: This study assessed the association between short-term weight change and
mammographic density in premenopausal women losing weight through diet and exercise to reduce
their risk of postmenopausal breast cancer. We aimed to understand whether a reduction in body
mass index affects various components of the breast, which could indicate a potential pathway for the
reduction in postmenopausal breast cancer risk seen with premenopausal weight loss. Understanding
this pathway is useful for monitoring the effectiveness of prevention strategies based on lifestyle
advice. We found that a short-term reduction in premenopausal body mass index through diet and
exercise is associated with a reduction in breast fat, but it is unlikely to have a significant effect on the
quantity of breast glandular tissue. Breast cancer risk determined by changes in breast density might
not capture potential weight loss-induced breast cancer risk reduction, instead falsely ascribing an
increased risk due to increased percent density.
Abstract: We evaluated the association between short-term change in body mass index (BMI) and
breast density during a 1 year weight-loss intervention (Manchester, UK). We included 65 pre-
menopausal women (35–45 years, ≥7 kg adult weight gain, family history of breast cancer). BMI and
breast density (semi-automated area-based, automated volume-based) were measured at baseline,
1 year, and 2 years after study entry (1 year post intervention). Cross-sectional (between-women)
and short-term change (within-women) associations between BMI and breast density were measured
using repeated-measures correlation coefficients and multivariable linear mixed models. BMI was
positively correlated with dense volume between-women (r = 0.41, 95%CI: 0.17, 0.61), but less so
within-women (r = 0.08, 95%CI: −0.16, 0.28). There was little association with dense area (between-
women r = −0.12, 95%CI: −0.38, 0.16; within-women r = 0.01, 95%CI: −0.24, 0.25). BMI and breast fat
were positively correlated (volume: between r = 0.77, 95%CI: 0.69, 0.84, within r = 0.58, 95%CI: 0.36,
0.75; area: between r = 0.74, 95%CI: 0.63, 0.82, within r = 0.45, 95%CI: 0.23, 0.63). Multivariable
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models reported similar associations. Exploratory analysis suggested associations between BMI
gain from 20 years and density measures (standard deviation change per +5 kg/m2 BMI: dense area:
+0.61 (95%CI: 0.12, 1.09); fat volume: −0.31 (95%CI: −0.62, 0.00)). Short-term BMI change is likely to
be positively associated with breast fat, but we found little association with dense tissue, although
power was limited by small sample size.
Keywords: mammographic density; body mass index; weight loss; breast cancer risk; breast cancer
prevention; premenopausal
1. Introduction
Mammographic density (herein referred to as ‘density’) is an established risk factor
for breast cancer. Women in the highest density category are at a 4- to 6-fold increased
risk of breast cancer relative to those with little or no dense tissue [1]. When assessed by
mammography, the breast is broadly characterised by two components: fibroglandular
dense tissue and fatty non-dense tissue. Percent breast density is measured as the relative
proportion of dense tissue in the breast, either in terms of area or volume depending
on the measurement method. Visual assessment measures percent density with respect
to the total breast area (TA) whilst automated and semi-automated methods can also
measure the extent of dense and fatty tissue separately. Both absolute dense area (DA) and
percentage dense area (PDA) are positively associated with risk of premenopausal (and
postmenopausal) breast cancer [2–4], and absolute dense volume (DV) and percentage
dense volume (PDV) have also shown positive associations [5,6]. Associations of breast
fat area (FA) and volume (FV) with breast cancer risk are unclear, although there is some
suggestion of an inverse relationship with premenopausal breast cancer risk [4,6].
In postmenopausal women, higher attained body mass index (BMI) is associated
with a higher risk of breast cancer [7–9], with an estimated 40% increase in risk for ev-
ery 10 kg/m2 of BMI in never users of hormone replacement therapy [9]. This increase
in risk is partly explained by increased aromatisation of androgens to oestrogen in pe-
ripheral adipose tissue, which promotes cell proliferation [10,11], carcinogenesis [10,11],
and insulin resistance [12]. Whilst BMI is a widely accepted risk factor for breast can-
cer in postmenopausal women, there may be an inverse relationship in premenopausal
women [13].
Weight gain across the premenopausal years has also been linked to an increased risk
of postmenopausal breast cancer. Every 5 kg of adult weight gain is associated with an
approximate 10% increase in risk amongst never or low-hormone replacement therapy
users [14,15]. However, a number of studies (as summarised by Hardefeldt et al. [16])
suggest that these effects are reversible with efficient weight loss [16]. In particular, weight
loss in the premenopausal years has been shown to reduce postmenopausal breast can-
cer risk [17,18]. Risk reductions of approximately 40% have also been seen with large
weight losses as a result of bariatric surgery in populations of pre- and postmenopausal
women [19].
The effects of short-term weight change on breast density are less well understood,
particularly those as a result of dietary weight loss. Mammographic density is a dynamic
phenotype and has the potential to respond to short-term weight changes, making density
reduction a possible biomarker for reduction in risk as a result of weight loss. This study
aims to explore the effect of short-term dietary weight change on density using both area-
based and volumetric methods in a cohort of premenopausal women to ascertain whether
the relationship between weight loss and reduced postmenopausal breast cancer risk could,
in part, be mediated by reductions in mammographic tissue.
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2. Materials and Methods
2.1. Study Design and Participants
The Lifestyle Study is a prospective non-randomised 1 year diet and exercise weight
loss intervention study amongst 79 high-risk premenopausal women attending annual
screening within the Breast Cancer Family History clinic at the Prevent Breast Cancer
research unit at the Manchester University Hospital Foundation NHS Trust [20–23]. Atten-
dees of our regional Family History Clinic, aged 35–45 years, received a mailed invitation
to enter either a 12-month intensive diet and exercise weight loss programme or a usual
care group receiving standard written advice only, depending on their proximity to the
hospital. Eligibility required women to be premenopausal with regular menstrual cycles,
non-smokers, have a self-reported adult weight gain ≥ 7 kg, and a sedentary lifestyle
(<40 min moderate physical activity per week). All women had a family history of breast
cancer (with lifetime risk 17–40% as assessed by the Tyrer–Cuzick model [24,25]), but
were excluded if they had a known BRCA1/2 mutation or a previous history of cancer.
Women were also excluded if they were already successfully dieting or losing weight, were
pregnant or planning to become pregnant over the next year, had used hormonal oral
contraceptives in the last six months, or had psychiatric or physical co-morbidities that
could affect their ability to take part in a diet and physical activity weight loss programme.
In the intervention group (n = 40), women followed a 12-month intensive supervised
weight loss programme involving a 25% energy-restricted Mediterranean type diet and an
individualised physical activity program (150 min moderate intensity physical activity and
40 min of resistance exercise per week). The usual care group (n = 39) received standard
written advice about diet and physical activity but no additional support for weight loss.
Women provided baseline information on alcohol intake (from a 4-day food diary) and
physical activity (7-day recall from an interview questionnaire) at their baseline clinic visit.
All subjects gave their informed consent for inclusion before they participated in the study.
The study was conducted in accordance with the Declaration of Helsinki, and the protocol
was approved by the South Manchester Ethics Committee (Reference no. 01/426).
The objective of this analysis was to assess the relationship between BMI and breast
density in the entire cohort of women. All participants had changing BMI measures
irrespective of the type of weight loss advice they received, hence the intervention and
usual care groups were combined and treated as one cohort. Furthermore, to limit the effect
of women contributing observations to an area-based measure or volumetric measure only,
the cohort was restricted to those with both an area and volumetric density measurement
at any one or more time points (n = 65, 82% of the cohort).
2.2. Mammographic Density
Mammographic films were digitised using a Kodak LS85 digitiser at a pixel size of
50 µm and with 12-bits (4096 grey levels) pixel depth. The images were then anonymised
and randomised to ensure the radiologists remained unaware of the time point of each
mammogram. Mammograms were analysed using three different methods: (1) a semi-
automated area-based measure based on computer-assisted thresholding by a single expert
user (Cumulus, Sunnybrook health sciences centre, Toronto, Canada, [26]); (2) an automated
volumetric Stepwedge method developed at Manchester University [27]; and (3) a visual
assessment score of percentage density read to the nearest 5% by two experienced readers
and expressed as an average of the two scores to calculate PDA. Cumulus was used to
calculate TA, DA, FA, and PDA, and the Manchester Stepwedge method calculated total
volume (TV), DV, FV, and PDV. Density assessments were made at 3 time points: baseline,
1 year follow-up (at the end of the intervention) and 1 year after the end of the intervention.
Baseline mammograms were taken at the point of entry to the study; for those women
with a mammogram performed within one year of entry, their most recent mammogram
within the last 12 months was used. Each woman had four mammographic views taken
at each time point: Left Cranial-Caudal, Right Cranial-Caudal, Left Mediolateral-Oblique,
and Right Mediolateral-Oblique, and a final mammographic score at each time point
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was calculated using an average of the four views. The main analysis refers to Cumulus
measured area-based density and Stepwedge measured volumetric density only to assess
the effects of BMI on dense and non-dense tissue separately. Visually-assessed density
had similar results to Cumulus-assessed PDA, so was included as a secondary density
measure only. Results for TA and TV are also reported as secondary density measures in
the Supplementary Materials.
2.3. Body Weight and Body Composition
Weight, BMI, and a variety of different measures of body composition were assessed
at baseline, 1 year follow-up (at the end of the intervention), and 1 year after the end of
the intervention. Weight (kg) and height (m) were determined using a calibrated beam
balance and stadiometer and used to calculate BMI (kg/m2). Other body composition
assessments were also made such as waist circumference; total body fat, fat free mass and
% body fat (assessed using a DXA whole body scanner (Hologic Inc., Bedford, MA, USA)
and bioelectrical impedance (Tanita TBF-300A, Tanita Europe B.V., Hoogoorddreef 56E,
1101 BE Amsterdam, The Netherlands)); and intra-abdominal and abdominal subcutaneous
area (assessed using a magnetic resonance imaging (MRI) scan with a single transverse scan
taken at the level of the intervertebral disc between the L2 and L3 vertebrae). Weight, BMI,
waist circumference, and total body fat, fat free mass, and % body fat (impedance) were
recorded at all three time points. Intra-abdominal area, abdominal subcutaneous area, and
total body fat, fat free mass, and % body fat (DXA) were only measured at baseline and at
1 year. Weight at age 20 years was self-reported via questionnaire, and BMI at age 20 years
was calculated using weight at age 20 years and height at study entry. Long-term adult
BMI gain was calculated as the difference between baseline BMI and BMI at age 20 years.
We discuss BMI as the measure of body weight throughout the main analysis because BMI
is a commonly used adjustment for density and it is a well-established risk factor for breast
cancer. Other body composition measures gave similar correlations with density to those of
BMI and were highly correlated with BMI. Therefore, other body composition measures are
included as secondary analyses in the Supplementary Materials. Weight gain during the
intervention was defined as ≥+3% of baseline weight, weight loss was defined as ≤−3%
of baseline weight, and a weight change >−3% to <+3% of the baseline weight was defined
as a stable weight [28].
2.4. Statistical Analysis
Data were visualised using custom-made ‘tadpole plots’, where each tadpole repre-
sents a woman, the head plots the woman’s BMI and density at her last time point, and the
points on the tail plot her BMI and density at earlier time points. Correlation (r) between
BMI and mammographic density was assessed on a cross-sectional basis (between women),
and within women as their short-term BMI changed, using repeated measures methods that
use all of the measurements at the same time [29,30]. Briefly, between women correlation
was a weighted Pearson correlation coefficient [30], and within women correlation was
based on the decomposition of sums of squares from an analysis of variance [29]. The
95% confidence intervals were estimated using an empirical bootstrap (10,000 resamples).
The simultaneous association of between and within women correlations was tested using
a linear mixed model adjusted for age [31] (Appendix A). To help with comparisons across
different measures of breast density, the breast density values were first standardised
(Appendix B). To make density measures more symmetric and approximately normally-
distributed, they were transformed: a square root transformation for area measures and a
cube root transformation for volumetric measures. An exploratory analysis was undertaken
to assess the effect of adding BMI gain since 20 years of age to the model. An additional ex-
ploratory analysis tested whether there was an association between breast density and DXA
bone density. A sensitivity analysis assessed repeated measures correlation coefficients for
BMI and density stratified by intervention group.
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Analysis used the statistical software R [32]. All tests were two-sided and considered
significant at the 5% level.
3. Results
Baseline characteristics of the cohort are shown in Table 1. Median age was 41 years
(interquartile range (IQR), 38–43 years), and the majority of women were Caucasian (n = 60,
92%) and parous (n = 55, 85%). At baseline, 27 women (42%) were classified as overweight
(BMI ≥ 25 kg/m2 and <30 kg/m2), 20 (31%) were obese (BMI ≥ 30 kg/m2), and 18 (28%)
were in the normal BMI range (BMI ≥ 18.5 kg/m2 and <25 kg/m2). By the end of the
2 year study period (1 year post intervention), 22 women (34%) had lost weight, 16 (25%)
had gained weight, and 26 (41%) maintained their original weight. Overall, women in
the intervention group lost more weight than the usual care group (mean percentage of
baseline weight at 1 year = −4.4% and 0.1%, respectively; mean percentage of baseline
weight at 2 years = −2.9% and 2.0%, respectively).
Median PDA, DA, and FA of each woman’s average density measure over the inter-
vention were 37.1% (IQR, 2.5%–71.3%), 59.9 cm2 (IQR, 5.8–158.4 cm2) and 107.3 cm2 (IQR,
23.6–405.1 cm2), respectively. For Stepwedge measures, PDV, DV, and FV were 22.7% (IQR,
6.7%–69.4%), 191.5 cm3 (IQR, 56.7–710.4 cm3), and 573.0 cm3 (IQR, 72.8–1992.1 cm3), respec-
tively. A flow chart detailing the availability of mammographic density measures across
the intervention is shown in Figure S1 (all women had BMI available at all time-points
except for one woman with missing BMI at 2 years—this data point was excluded from
analyses involving BMI).
Table 2 shows the repeated measures correlations. DV was positively correlated with
BMI between women (r = 0.41, 95%CI 0.17 to 0.61) but less so within women (r = 0.08, 95%CI
−0.16 to 0.28). There was little association between DA and BMI (between women r =−0.12,
95%CI −0.38 to 0.16; within women r = 0.01, 95%CI −0.24 to 0.25). PDV was inversely
associated with BMI between and within women (between r =−0.48, 95%CI −0.64 to−0.33;
within r = −0.36, 95%CI −0.54 to −0.12), and PDA was inversely associated with BMI
between women (r = −0.58, 95%CI −0.72 to −0.42), but less so within women (r = −0.22,
95%CI −0.44 to 0.01). FV and FA were positively correlated with BMI between and within
women (volume: between r = 0.77, 95%CI 0.69 to 0.84, within r = 0.58, 95%CI 0.36 to
0.75; area: between r = 0.74, 95%CI 0.63 to 0.82, within r = 0.45, 95%CI 0.23 to 0.63).
The magnitude of correlations was stronger between women than within women. These
associations were also seen in Figure 1 when data were visually assessed using tadpole
plots (trends in the tadpole heads represented the between women correlations and trends
in the tadpole tails represented within women correlations).
Results for repeated measures correlation coefficients were similar when evaluated in a
sensitivity analysis stratifying the cohort by intervention group. Within women associations
for BMI and FA or FV were slightly stronger for women following the supervised weight
loss programme compared with the usual care group, but there was little association
(within women) for BMI and DA or DV in both intervention groups (Table S6).
Other body fat composition measures were highly correlated with BMI (Table S3),
and the associations between breast density and other body fat compositions were similar
to those with BMI (Tables S1 and S2). The correlations between various mammographic
density measures are also reported in the Supplementary Materials (Table S4).
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Table 1. Participant characteristics at study entry.
Characteristic All Intervention Usual Care
Total 65 33 32
Age * (years) 41 (38–43) 41 (39–43) 40 (38–42)
Baseline BMI * (kg/m2) 27.1 (24.7–33.4) 27.1 (25.1–31.9) 27.0 (24.4–34.0)
Baseline BMI categories # (kg/m2)
Normal (≥18.5 to <25) 18 (28%) 7 (21%) 11 (34%)
Overweight (≥25 to <30) 27 (42%) 16 (48%) 11 (34%)
Obese (≥30) 20 (31%) 10 (30%) 10 (31%)
BMI gain since 20 years * (kg/m2) 5.8 (4.7–9.4) 6.3 (4.7–10.0) 5.7 (4.6–8.9)
Height * (m) 1.64 (1.60–1.68) 1.63 (1.60–1.68) 1.65 (1.59–1.68)
Age at menarche * (years) 12 (12–13) 12 (12–13) 12 (12–13)
Number of live births #
Nulliparous 10 (15%) 6 (18%) 4 (13%)
1–2 41 (63%) 20 (61%) 21 (66%)
3–4 12 (18%) 6 (18%) 6 (19%)
≥5 2 (3%) 1 (3%) 1 (3%)
Age first live birth * (years) 27 (22–29) 27 (24–31) 26 (22–29)
Ethnicity # (% Caucasian) 60 (92%) 29 (88%) 31 (97%)
Previous smoker #
Never 54 (83%) 29 (88%) 25 (78%)
Ever 11 (17%) 4 (12%) 7 (22%)
Previous oral contraception use #
Never 5 (8%) 3 (9%) 2 (6%)
Ever 58 (89%) 29 (88%) 29 (91%)
Unknown 2 (3%) 1 (3%) 1 (3%)
Breastfed #
Never 22 (34%) 12 (36%) 10 (31%)
Ever 41 (63%) 21 (64%) 20 (63%)
Unknown 2 (3%) 0 (0%) 2 (6%)
10-year Tyrer–Cuzick risk * (%) 4 (3–5) 5 (4–6) 3 (3–4)
Alcohol intake a,* (units/week) 11 (3–24) 11 (3–22) 10 (1.5–26)
Physical activity b,* ((kJ/kg)/week) 974 (945–999) 968 (941–999) 978 (953–1007)
Weight change from baseline to 1 year, categories #
Loss 26 (40%) 20 (61%) 6 (19%)
Stable 27 (42%) 9 (27%) 18 (56%)
Gain 12 (18%) 4 (12%) 8 (25%)
Weight change from baseline to 1 year ** −2.2 (5.4) −4.4 (5.0) 0.1 (4.8)
Weight change from baseline to 2 years, categories #
Loss 22 (34%) 16 (48%) 6 (19%)
Stable 26 (41%) 13 (39%) 13 (42%)
Gain 16 (25%) 4 (12%) 12 (39%)
Weight change from baseline to 2 years ** −0.5 (7.1) −2.9 (6.2) 2.0 (7.1)
BMI: Body mass index. # N (%); * Median (interquartile range); ** Mean (standard deviation) % of baseline weight (kg). a Alcohol from a
4-day food diary; b Physical activity from 7-day recall. Weight loss defined as ≤−3% of baseline weight (kg); Stable weight defined as
>−3% to <+3% of baseline weight (kg); Weight gain defined as ≥+3% of baseline weight (kg).
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Figure 1. Tadpole plots showing body mass index (BMI) and density measures across the 2 year 
follow-up. Each tadpole represents a woman: the tadpole head shows BMI and density (if density 
is available) at her last follow-up and the points on the tail show BMI and density (if density is 
available) at her earlier follow-ups. (a) Dense volume; (b) Fat volume; (c) Dense area; (d) Fat area. 
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to those with BMI (Tables S1 and S2). The correlations between various mammographic 
density measures are also reported in the Supplementary Materials (Table S4). 
The between and within women associations for density and BMI measures were 
similar when estimated jointly in an age-adjusted linear mixed model (Table 3). In a sen-
sitivity analysis, the same model was fit using weight instead of BMI, but it had a worse 
model fit for almost all density measures (Table S5). 
  
Figure 1. Tadpole plots showing body mass index (BMI) and density measures across the 2 year follow-up. Each tadpole
represents a woman: the tadpole head shows BMI and density (if density is available) at her last follow-up and the points on
the tail show BMI and density (if density is available) at her earlier follow-ups. (a) Dense volume; (b) Fat volume; (c) Dense
area; (d) Fat area.
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The between and within women associations for density and BMI measures were
similar when estimated jointly in an age-adjusted linear mixed model (Table 3). In a
sensitivity analysis, the same model was fit using weight instead of BMI, but it had a worse
model fit for almost all density measures (Table S5).
Table 3. Multivariable linear mixed model fit results for mammographic density on body mass index (between and within
women), adjusted for age (A1).





VAS (sqrt%) 3.75 (1.88 to 5.61) −0.19 (−0.56 to 0.19) −0.51 (−0.68 to −0.35) −0.27 (−0.44 to −0.10)
PDA (sqrt%) 2.87 (0.57 to 5.17) −0.05 (−0.53 to 0.43) −0.46 (−0.63 to −0.30) −0.32 (−0.59 to −0.05)
PDV (cbrt%) 1.73 (−1.07 to 4.53) 0.12 (−0.48 to 0.71) −0.39 (−0.57 to −0.21) −0.85 (−1.32 to −0.39)
FA (sqrt) −3.63 (−5.25 to −2.02) 0.04 (−0.28 to 0.36) 0.60 (0.46 to 0.74) 0.43 (0.27 to 0.58)
FV (cbrt) −3.46 (−5.27 to −1.64) −0.04 (−0.42 to 0.34) 0.63 (0.50 to 0.76) 0.79 (0.56 to 1.03)
DA (sqrt) 0.57 (−2.13 to 3.27) −0.03 (−0.59 to 0.53) −0.08 (−0.28 to 0.11) 0.01 (−0.30 to 0.33)
DV (cbrt) −2.39 (−5.11 to 0.33) 0.09 (−0.48 to 0.66) 0.35 (0.16 to 0.53) 0.16 (−0.24 to 0.55)
VAS: Visual assessment score; PDA: percent dense area; PDV: percent dense volume; FA: fat area; FV: fat volume; DA: dense area; DV: dense
volume; sqrt: square root transformed; cbrt: cube root transformed; BMI: body mass index; 95%CI: 95% confidence interval. Area-based
measures from Cumulus; volumetric measures from Manchester Stepwedge. Between women BMI calculated as the mean BMI for
each woman; within women BMI calculated as the difference between each woman’s BMI and her mean BMI. Density measures are
standardised (see Appendix B). One woman with missing BMI at age 20 years excluded. Within women effects represent trends over the
entire 2 year period.
When a term for BMI gain since age 20 years was added to the linear mixed model,
the model fit improved for PDA, PDV, FV, and DA (all ∆LR-χ2 p < 0.05) (Table 4). After
including BMI gain since age 20 years, between women associations for BMI became more
strongly inversely associated with percent density (approximately −0.5 to −0.8), more
strongly positively associated with breast fat (approximately 0.6 to 0.8), more strongly
inversely associated with DA (−0.1 to −0.5), and less strongly positively associated with
DV (0.4 to 0.2). Within women effects of BMI on density were almost unchanged when
including BMI gain since age 20 years. BMI gain from age 20 years (adjusted for attained
BMI) was positively associated with DA, PDA, and PDV (5 kg/m2 increase in BMI gain
since age 20 years was associated with 0.61 (95%CI 0.12 to 1.09), 0.61 (95%CI 0.21 to 1.02),
and 0.47 (95%CI 0.05 to 0.88) standard deviation increase in breast density (β), respectively),
and inversely associated with FV (β = −0.31, 95%CI −0.62 to 0.00), but less association was
seen with DV (β = 0.15, 95%CI −0.29 to 0.59) and FA (β = −0.32, 95%CI −0.67 to 0.03).
Finally, in tests of association between breast and bone density, there was some
indication of a positive between women correlation for bone density and FV (r = 0.26,
95%CI, 0.00 to 0.50), DV (r = 0.33, 95%CI, 0.09 to 0.54), and TV (r = 0.31, 95%CI, 0.06 to 0.54)
(Table S1), but we found little correlation within women (Table S2).
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Table 4. Multivariable linear mixed model fit results for mammographic density on body mass index (between and within women) and body mass index gain since 20 years of age,
adjusted for age (A2).





BMI Gain Since 20 Years




VAS (sqrt%) 5.47 (3.34 to 7.60) −0.25 (−0.61 to 0.12) −0.92 (−1.23 to −0.62) −0.27 (−0.45 to −0.10) 0.59 (0.20 to 0.97) 0.0031
PDA (sqrt%) 4.90 (2.34 to 7.46) −0.16 (−0.63 to 0.31) −0.89 (−1.22 to −0.57) −0.32 (−0.59 to −0.06) 0.61 (0.21 to 1.02) 0.0033
PDV (cbrt%) 3.35 (0.30 to 6.40) 0.01 (−0.57 to 0.60) −0.71 (−1.05 to −0.38) −0.85 (−1.32 to −0.39) 0.47 (0.05 to 0.88) 0.0267
FA (sqrt) −4.59 (−6.49 to −2.69) 0.08 (−0.24 to 0.40) 0.82 (0.54 to 1.10) 0.43 (0.28 to 0.59) −0.32 (−0.67 to 0.03) 0.0704
FV (cbrt) −4.42 (−6.44 to −2.40) 0.01 (−0.37 to 0.38) 0.84 (0.59 to 1.09) 0.79 (0.56 to 1.03) −0.31 (−0.62 to 0.00) 0.0476
DA (sqrt) 2.58 (−0.48 to 5.64) −0.14 (−0.70 to 0.41) −0.51 (−0.90 to −0.12) 0.01 (−0.31 to 0.32) 0.61 (0.12 to 1.09) 0.0145
DV (cbrt) −1.90 (−4.96 to 1.15) 0.06 (−0.51 to 0.64) 0.24 (−0.12 to 0.60) 0.16 (−0.24 to 0.55) 0.15 (−0.29 to 0.59) 0.4967
VAS: Visual assessment score; PDA: percent dense area; PDV: percent dense volume; FA: fat area; FV: fat volume; DA: dense area; DV: dense volume; sqrt: square root transformed; cbrt: cube root transformed;
BMI: body mass index; 95%CI: 95% confidence interval. Area-based measures from Cumulus; volumetric measures from Manchester Stepwedge. Between women BMI calculated as the mean BMI for each
woman; within women BMI calculated as the difference between each woman’s BMI and her mean BMI; BMI gain from age 20 years calculated as the difference between each woman’s BMI at baseline and her
BMI at age 20 years. Density measures are standardised (see Appendix B). One woman with missing BMI at age 20 years excluded. ∆LR-χ2 represents the difference in likelihood ratio for A1 versus A2. Within
women effects represent trends over the entire 2 year period. All variables adjusted for each other in the multivariable model, therefore BMI gain since 20 years of age is adjusted for current BMI through the
variable for between women BMI.
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4. Discussion
The data in this study provide some support for the two main findings. First, it is
possible that the higher a premenopausal woman’s BMI, the higher her breast fat and dense
tissue (in particular, dense volume), and the lower her percent density. Second, the data
suggested that as a premenopausal woman loses weight, her breast fat reduces, dense tissue
remains relatively unchanged, and percent dense tissue increases. Effective weight loss
during premenopausal years has been associated with a reduced risk of postmenopausal
breast cancer [16–18], but our study data suggest that risk reduction is unlikely to be
mediated by a short-term reduction in dense breast tissue. This is likely to mean that
incorporation of change in percent breast density into risk algorithms will not capture
potential weight loss-induced breast cancer risk reduction and may falsely ascribe an
increased risk due to increased percent density. Therefore, risk prediction models need to
consider how best to incorporate changes in weight and mammographic density when
predicting breast cancer risk.
The between women associations of attained premenopausal BMI and breast density
observed in this study were consistent with previous studies. High BMI is associated
with high dense volume [33–35], but the correlation between BMI and dense area is less
strong, and often close to zero [36–39]. These differences are likely to be a result of
volumetric measures representing breast tissue more accurately than area-based methods
by accounting for breast thickness and overlapping tissue. Additionally, since the breast is a
deposit for adipose tissue, high attained BMI is strongly associated with high levels of breast
fat area [36–39] and breast fat volume [33,34], which in turn leads to an inverse association
between BMI and both percent dense area [36–41] and percent dense volume [33–35,42,43].
There have been very few studies to assess the effect of dietary weight loss on breast
density in premenopausal women. Boyd et al. reported reductions in total and dense
area alongside modest weight change within an intervention trial of women on a 2-year
low-fat, high-carbohydrate diet [44]. In particular, a 5.4% decrease in dense area was
seen in premenopausal women in the low-fat diet group with a 0.1kg/m2 BMI reduction
(n = 249) compared with a 2.5% decrease in the control group with a 0.3kg/m2 BMI gain
(n = 264). These reductions may be associated with the large reductions in dietary fat (55
to 35 g/day) and saturated fat (19 to 12 g/day) rather than weight loss in this study. This
was considerably higher than those advised and achieved in the current reported study
(total fat reduced from 77 to 60 g/day and saturated fat reduced from 28 to 21 g/day).
Other trials have also assessed the effect of lifestyle interventions for weight loss on breast
density, although in postmenopausal women only. In the ALPHA trial, postmenopausal
women on a 1-year aerobic exercise intervention lost on average 39 cm3 more breast fat
than the controls, but there was little difference in the change in dense tissue between
the two groups [45]. Furthermore, the DAMA trial reported a reduction in volumetric
percent density of approximately 14% for postmenopausal women following a 2-year diet
or exercise intervention when compared with the controls [46]. Large weight loss with
bariatric surgery is also associated with large reductions in breast fat alongside relatively
smaller reductions in dense tissue, and an increase in percent density [47–49].
As an exploratory analysis, we also found an association between increased BMI
gain since 20 years of age and higher dense tissue and percent density. It is possible
that this is a pathway for the increased risk of postmenopausal breast cancer seen with
adult weight gain [7,15,50–52]. However, this association is likely to reflect the inverse
association seen in previous studies between adolescent body adiposity and dense tissue
in later life [38,40,53–55], since, given the adjustment for current BMI, women with greater
gain in BMI will have had lower BMI at 20 years of age. This interesting observation
requires further investigation in larger datasets of women. Additionally, exploratory
analysis of bone density found little association with breast density, which is in agreement
with previous studies [56].
Strengths of this study include the various measures of breast density including
Cumulus and the Stepwedge method, which allowed for the assessment of dense and fatty
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tissue separately as well as various measures of body weight to assess adiposity. The study
also assessed breast density as an area-based measure and volumetrically; both of which
have similar abilities for breast cancer risk prediction [57]. Additionally, all women were
encouraged to lose weight, which produced data with large within women variation in
BMI, in turn increasing the potential to see an effect of changing BMI on mammographic
density. Furthermore, the Lifestyle Study provided a data source to assess premenopausal
weight loss and density associations; something that is not possible in studies involving
routine screening data. This also provided a greater ability to capture the effects of weight
loss on density because this cohort of premenopausal women were likely to have had
higher dense tissue at baseline (with greater ability to decrease) than screening populations
involving postmenopausal women [58]. Finally, the use of repeated measures over a 2-year
period allowed us to assess the association between BMI and breast density longitudinally,
whilst making use of all available data simultaneously.
Limitations of the study include the small sample size, which limits statistical power.
This is particularly relevant for volumetric measures, which had a moderate amount of
missing data at the baseline. In addition, the study design was not powered for the analysis
of mammographic density, which was a secondary analysis (the study was powered for
salivary oestradiol). This was a relatively small study, and ideally, a larger study with
sufficient power would be run to verify our evidence. Another limitation is the analysis of
BMI gain since 20 years of age relies on self-reported information on weight at age 20 years.
This may be less accurate than the measured values. However, validation studies show that
self-reported BMI is highly correlated with independently measured BMI, and the mean
difference between self-reported and measured weight is minimal [59,60]. Finally, breast
thickness is likely to have changed whilst women lost weight during the intervention.
Volumetric measures are influenced by breast thickness [61], hence there might have been
larger variation in the serial compared with stable volumetric measurements, resulting in
reduced ability to capture the within women effects of BMI on dense tissue volumetrically.
5. Conclusions
This study suggests that premenopausal weight loss reduces breast fat but that it
does not reduce dense tissue. Short-term premenopausal weight loss is likely to be linked
to lower postmenopausal breast cancer risk through reductions in adipose tissue, not
fibroglandular tissue. This means that a potential breast cancer risk reduction as a result of
weight loss might not be captured by changes in breast density, and the resulting increase
in percent density may falsely ascribe an increase in risk. However, the study was limited
by the small sample size, and more studies are required to provide evidence to confirm
these results.
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DA dense area




PDV percent dense volume
FV fat volume
TV total volume
BMI body mass index
VAS visual assessment score
Appendix A
Linear mixed model for mammographic density on body mass index and age. A
linear mixed model was used to model density and body mass index (BMI) associations
in Table 3. This model allows for repeated measures and uses all of the available data
(missing pairs of density and BMI are excluded). Breast density yij for woman i = 1, . . . , n
at time j = {1, 2, 3} is modelled as:




+ ui + eij; (A1)
where α is an overall intercept; ageij is the age at baseline for woman i at time j; β is the
slope for age; xi. is mean BMI for woman i; γ is the between women slope; xij is the BMI
of woman i at time j; δ is the within women slope; and eij is an independent random
error. Another term that allows for differences between women in their overall density
level is the independent random intercept ui for woman i. The model is completed by
assuming normal distributions for ui and eij with zero mean, unknown variances, and
zero covariance. The model was fitted by maximum likelihood. To aid interpretation of
the estimates across different measures of density, the density values were standardised
(see Appendix B). To test γ = 0 (between women correlation) and δ = 0 (within women
correlation), a Wald test was applied.
The model was extended to consider BMI gain from age 20 years in Table 4:




+ ui + εzi + eij; (A2)
Cancers 2021, 13, 3245 13 of 15
where zi is the BMI gain since age 20 years for woman i: calculated as the difference
between baseline BMI for woman i and BMI at age 20 years for woman i, and ε is the slope
for BMI gain since age 20 years. To test ε = 0, a Wald test was applied.
Appendix B












where xi is the mean density for woman i = 1, . . . , n; dij is the density measure for woman
i = 1, . . . , n at time point j = {1, 2, 3}; and zij is the standardised density measure for
woman i at time point j.
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